Updated just now · Live
Stock analysis, price data, and AI-powered insights for Royalty Pharma PLC (RPRX).
Royalty Pharma PLC operates in the Pharmaceuticals sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for RPRX.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). RPRX Stock Intelligence Report. [stoxpulse.com/stocks/rprx]
Disclaimer: The information on this page about Royalty Pharma PLC (RPRX) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Royalty Pharma PLC.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Royalty Pharma plc Declares Dividend for the Secon...
4d ago
Royalty Pharma Declares Second Quarter 2026 Divide...
4d ago
StoxPulse AI results for RPRX: Pulse Score 57/100. Primary sentiment trends from 5 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$28.44B
P/E Ratio
—
EPS
$0.67
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Royalty Pharma plc Declares Dividend for the Second Quarter 2026, Payable on June 10, 2026
Royalty Pharma Declares Second Quarter 2026 Dividend
Royalty Pharma : Q1 2026 Pre-Quarterly Results Communication
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
Royalty Pharma : 2025 Corporate Responsibility Report pdf